Alkermes
UnverifiedManufacturerDublin, Ireland (US corporate office and R&D center: Waltham, Massachusetts)Founded 1987Nasdaq: ALKS
Overview
Alkermes is a global biopharmaceutical company focused on neuroscience, headquartered in Ireland with a corporate office and R&D center in Massachusetts. Its proprietary commercial products treat alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. It completed the acquisition of Avadel Pharmaceuticals on 12 February 2026, adding LUMRYZ and a narcolepsy commercial organisation. The 10-K reports one segment.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Alkermes’s careers page.
- Territory Business Manager, Rare Disease – Cedar Rapids / Peoria / RockfordDavenport, Iowa2d ago$150k–$185k
- Territory Business Manager Psychiatry – AugustaAugusta, Georgia3d ago$125k–$155k
- Territory Business Manager Psychiatry – YpsilantiYpsilanti, Michigan3d ago
- Territory Business Manager Psychiatry – Boston South / Rhode Island / Cape CodProvidence, Rhode Island5d ago$125k–$155k
- Territory Business Manager, Rare Disease – SeattleSeattle, Washington8d ago$150k–$185k
- Regional Business Director, Rare Disease - South CentralDallas, Texas9d ago$200k–$230k
Divisions
Division information is pending company verification.Once Alkermes claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Alkermes
These sections fill in when Alkermes claims and verifies its page.